Oragenics, Inc. (OGEN) has a market capitalization of $2.93M and trades at $0.68. The 52-week range is 0.5-9.6.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0.1, Earnings Per Share (EPS) of $-4.56.
The stock has a beta of 1.21, operates in the Healthcare sector.
